83 related articles for article (PubMed ID: 38686382)
21. Rare But Fatal: Hemophagocytic Lymphohistiocytosis (HLH) With Acute Acalculous Cholecystitis.
Javed F; Crouch J; Combs E
Cureus; 2022 Nov; 14(11):e31737. PubMed ID: 36569679
[TBL] [Abstract][Full Text] [Related]
22. COVID-19-associated acute appendicitis in adults. A report of five cases and a review of the literature.
Georgakopoulou VE; Gkoufa A; Damaskos C; Papalexis P; Pierrakou A; Makrodimitri S; Sypsa G; Apostolou A; Asimakopoulou S; Chlapoutakis S; Sklapani P; Trakas N; Spandidos DA
Exp Ther Med; 2022 Jul; 24(1):482. PubMed ID: 35761802
[TBL] [Abstract][Full Text] [Related]
23. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.
Stirton H; Shear NH; Dodiuk-Gad RP
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625735
[TBL] [Abstract][Full Text] [Related]
24. Characterizing DRESS syndrome recurrence: a systematic review.
Sharma AN; Shwe S; Ravi V; Miller M; Mesinkovska NA; Rojek NW; Worswick S
Arch Dermatol Res; 2022 Oct; 314(8):721-728. PubMed ID: 34505944
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
Ombrello MJ; Schulert GS
Transl Res; 2021 Jun; 232():1-12. PubMed ID: 33684592
[TBL] [Abstract][Full Text] [Related]
26. Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review.
Yang JJ; Lei DK; Ravi V; Maloney NJ; Crew A; Worswick S
Int J Dermatol; 2020 Sep; ():. PubMed ID: 32964443
[TBL] [Abstract][Full Text] [Related]
27. Pediatric hemophagocytic lymphohistiocytosis.
Canna SW; Marsh RA
Blood; 2020 Apr; 135(16):1332-1343. PubMed ID: 32107531
[TBL] [Abstract][Full Text] [Related]
28. Fatal sulfasalazine-induced DRESS complicated by HHV-6 reactivation and hemophagocytic lymphohistiocytosis.
Ammar H; Azouzi A; Fathallah N; Boujelben MA; Ouni B; Boussarsar M; Sriha B; Ben Salem C
Eur J Clin Pharmacol; 2020 Mar; 76(3):467-468. PubMed ID: 31853592
[No Abstract] [Full Text] [Related]
29. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily EM; Weiser P; Crayne CB; Haines H; Mannion ML; Stoll ML; Beukelman T; Atkinson TP; Cron RQ
Arthritis Rheumatol; 2020 Feb; 72(2):326-334. PubMed ID: 31513353
[TBL] [Abstract][Full Text] [Related]
30. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
[TBL] [Abstract][Full Text] [Related]
31. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.
Le RQ; Li L; Yuan W; Shord SS; Nie L; Habtemariam BA; Przepiorka D; Farrell AT; Pazdur R
Oncologist; 2018 Aug; 23(8):943-947. PubMed ID: 29622697
[TBL] [Abstract][Full Text] [Related]
32. Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients.
Liang J; Qu H; Wang X; Wang A; Liu L; Tu P; Li R; Wang M
Ann Dermatol; 2018 Feb; 30(1):71-74. PubMed ID: 29386835
[TBL] [Abstract][Full Text] [Related]
33. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.
Rivière S; Galicier L; Coppo P; Marzac C; Aumont C; Lambotte O; Fardet L
Am J Med; 2014 Nov; 127(11):1118-1125. PubMed ID: 24835040
[TBL] [Abstract][Full Text] [Related]
34. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
[TBL] [Abstract][Full Text] [Related]
35. The expanding spectrum of hemophagocytic lymphohistiocytosis.
Filipovich AH
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):512-6. PubMed ID: 21971331
[TBL] [Abstract][Full Text] [Related]
36. The DRESS syndrome: a literature review.
Cacoub P; Musette P; Descamps V; Meyer O; Speirs C; Finzi L; Roujeau JC
Am J Med; 2011 Jul; 124(7):588-97. PubMed ID: 21592453
[TBL] [Abstract][Full Text] [Related]
37. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.
Walsh SA; Creamer D
Clin Exp Dermatol; 2011 Jan; 36(1):6-11. PubMed ID: 21143513
[TBL] [Abstract][Full Text] [Related]
38. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.
Kano Y; Ishida T; Hirahara K; Shiohara T
Med Clin North Am; 2010 Jul; 94(4):743-59, xi. PubMed ID: 20609861
[TBL] [Abstract][Full Text] [Related]
39. Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients.
Ang CC; Wang YS; Yoosuff EL; Tay YK
J Am Acad Dermatol; 2010 Aug; 63(2):219-27. PubMed ID: 20605253
[TBL] [Abstract][Full Text] [Related]
40. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.
Eshki M; Allanore L; Musette P; Milpied B; Grange A; Guillaume JC; Chosidow O; Guillot I; Paradis V; Joly P; Crickx B; Ranger-Rogez S; Descamps V
Arch Dermatol; 2009 Jan; 145(1):67-72. PubMed ID: 19153346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
